Spero Therapeutics, Inc. Annual Nonoperating Income (Expense) in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Spero Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2018 to 2023.
  • Spero Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was $1.2M, a 22.8% increase year-over-year.
  • Spero Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was $4.5M, a 52.8% increase year-over-year.
  • Spero Therapeutics, Inc. annual Nonoperating Income (Expense) for 2023 was $3.92M.
  • Spero Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was -$4.22M, a 136% decline from 2021.
  • Spero Therapeutics, Inc. annual Nonoperating Income (Expense) for 2021 was -$1.79M, a 314% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $3.92M +$8.14M Jan 1, 2023 Dec 31, 2023 10-K 2024-03-13
2022 -$4.22M -$2.43M -136% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-13
2021 -$1.79M -$2.62M -314% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
2020 $833K -$1.46M -63.6% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
2019 $2.29M +$1.15M +100% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-11
2018 $1.14M Jan 1, 2018 Dec 31, 2018 10-K 2020-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.